Drug Target Review
JUNE 19, 2025
In the field of drug discovery, few areas face a more pressing need for innovation than pain management. For decades, opioids have dominated the space, but despite their effectiveness they are burdened by significant risks of dependence and misuse. As the limitations of current treatments become increasingly clear, researchers are exploring new, safer approaches.
Quanticate
JUNE 19, 2025
Clinical trials rely on comprehensive data collection to prove the investigational drug/device’s efficacy and safety, the Case Report Form (CRF), a structured document designed to record all trial-related data for each participant makes this possible. However, simply collecting data isn't enough, it must be clearly mapped to datasets required for regulatory submission, and that's where annotated CRFs (aCRFs) come in.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
JUNE 19, 2025
As funding becomes increasingly scarce and timelines grow tighter, life science researchers are re-evaluating how they operate. James Atwood, Chief Operating Officer of lab robotics company Opentrons , believes automation is the leveller that could reshape scientific discovery from the ground up. With a background spanning biopharma leadership, genomics and technology commercialisation, Atwood is helping to drive a shift towards more efficient and flexible lab operations.
Drug Channels
JUNE 19, 2025
This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors. Click here to see the original post from April 2025. It's time for Drug Channels ’ annual update of vertical integration among insurers, PBMs, specialty pharmacies, and healthcare services within U.S. drug channels.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Expert insights. Personalized for you.
52 
Let's personalize your content